Bereich
Gastroenterologie | Hepatologie
GASTRO · Dept. I
Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-aparaginase
Sulz M. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-aparaginase. Digestion 2006; 74:28-32.
11.12.2006Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-aparaginase
11.12.2006Digestion 2006; 74:28-32
Sulz Michael
• Serum immunoglobulin G4 (IgG4): An important marker for autoimmune pancreatitis?
Sulz M. • Serum immunoglobulin G4 (IgG4): An important marker for autoimmune pancreatitis?. Swiss Med Wkly 2006; 136:544-547.
11.12.2006• Serum immunoglobulin G4 (IgG4): An important marker for autoimmune pancreatitis?
11.12.2006Swiss Med Wkly 2006; 136:544-547
Sulz Michael
C-ANCA-negative small vessel vasculitis (Panarteriitis nodosa) with severe complication in the gastrointestinal tract
Sulz M. C-ANCA-negative small vessel vasculitis (Panarteriitis nodosa) with severe complication in the gastrointestinal tract. Swiss Med Forum 2006; 6:804-806.
11.12.2006C-ANCA-negative small vessel vasculitis (Panarteriitis nodosa) with severe complication in the gastrointestinal tract
11.12.2006Swiss Med Forum 2006; 6:804-806
Sulz Michael
Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis
Seiderer J, Lohse P, Göke B, Sackmann M, Tillack C, Dambacher J, Hofbauer K, Herrmann K, Pfennig S, Staudinger T, Brand S, Schnitzler F, Ochsenkühn T. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol 2006; 41:1421-32.
01.12.2006Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis
01.12.2006Scand J Gastroenterol 2006; 41:1421-32
Seiderer Julia, Lohse Peter, Göke Burkhard, Sackmann Michael, Tillack Cornelia, Dambacher Julia, Hofbauer Katrin, Herrmann Karin, Pfennig Simone, Staudinger Tanja, Brand Stephan, Schnitzler Fabian, Ochsenkühn Thomas
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study
Seiderer J, Lohse P, Göke B, Schoenberg S, Pfennig S, Crispin A, Hatz R, Schnitzler F, Herrmann K, Brand S, Ochsenkühn T. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study. Inflamm Bowel Dis 2006; 12:1114-21.
01.12.2006Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study
01.12.2006Inflamm Bowel Dis 2006; 12:1114-21
Seiderer Julia, Lohse Peter, Göke Burkhard, Schoenberg Stefan O, Pfennig Simone, Crispin Alexander, Hatz Rudolf, Schnitzler Fabian, Herrmann Karin A, Brand Stephan, Ochsenkühn Thomas
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Helbling B, Renner E, Meyer-Wyss B, Esteban A, Mullhaupt B, Dinges S, Wilhelmi M, Gonvers J, Borovicka J, Cerny A, Knöpfli M, Stamenic I, Jochum W, Swiss Association for the Study of the Liver (SASL). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis 2006; 13:762-9.
01.11.2006HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
01.11.2006Journal of viral hepatitis 2006; 13:762-9
Helbling Beat, Renner Eberhard L, Meyer-Wyss Beat, Esteban Alicia, Mullhaupt Beat, Dinges Sabine, Wilhelmi Martin, Gonvers Jean-Jacques, Borovicka Jan, Cerny Andreas, Knöpfli Marina, Stamenic Ivan, Jochum Wolfram, Swiss Association for the Study of the Liver (SASL)
Inhibition of alpha interferon signaling by hepatitis B virus
Christen V, Duong F, Bernsmeier C, Sun D, Nassal M, Heim M. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol 2006; 81:159-65.
25.10.2006Inhibition of alpha interferon signaling by hepatitis B virus
25.10.2006J Virol 2006; 81:159-65
Christen Verena, Duong Francois, Bernsmeier Christine, Sun Dianxing, Nassal Michael, Heim Markus H
The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease
Thalmaier D, Lohse P, Ochsenkühn T, Göke B, Crispin A, Otte J, Pfennig S, Schachinger V, Konrad A, Seiderer J, Dambacher J, Brand S. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 24:1105-15.
01.10.2006The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease
01.10.2006Aliment Pharmacol Ther 2006; 24:1105-15
Thalmaier D, Lohse P, Ochsenkühn T, Göke B, Crispin A, Otte J-M, Pfennig S, Schachinger V, Konrad A, Seiderer J, Dambacher J, Brand Stephan
Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses
Ulsenheimer A, Diepolder H, Wucherpfennig K, Pape G, Loughry A, Gruener N, Gerlach T, Seth N, Lucas M, Klenerman P. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. Journal of viral hepatitis 2006; 13:708-14.
01.10.2006Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses
01.10.2006Journal of viral hepatitis 2006; 13:708-14
Ulsenheimer A, Diepolder H M, Wucherpfennig K W, Pape G R, Loughry A, Gruener N H, Gerlach Tilman, Seth N P, Lucas M, Klenerman P
Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase
Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krähenbühl S. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase. Digestion 2006; 74:28-32.
19.09.2006Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase
19.09.2006Digestion 2006; 74:28-32
Bodmer Michael, Sulz Michael, Stadlmann Sylvia, Droll Armin, Terracciano Luigi, Krähenbühl Stephan
[Helicobacter pylori 2006: how to test, when to treat]
van der Weg B, Meyenberger C, Borovicka J. [Helicobacter pylori 2006: how to test, when to treat]. Praxis 2006; 95:1413-8.
13.09.2006[Helicobacter pylori 2006: how to test, when to treat]
13.09.2006Praxis 2006; 95:1413-8
van der Weg B, Meyenberger Christa, Borovicka Jan
Helicobacter pylori 2006: How to test, when to treat
van der Weg B, Meyenberger C, Borovicka J. Helicobacter pylori 2006: How to test, when to treat. Schweiz Rundsch Med Prax. 2006; 95:1413-1418.
13.09.2006Helicobacter pylori 2006: How to test, when to treat
13.09.2006Schweiz Rundsch Med Prax. 2006; 95:1413-1418
van der Weg B, Meyenberger Christa, Borovicka Jan
Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy
Borovicka J, Binek J, Zuercher U, Dorta G, Bauerfeind P, Ehmann T, Gschossmann J, Netzer P, Neuweiler J, Fischer J, Meyenberger C. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Endoscopy 2006; 38:867-72.
01.09.2006Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy
01.09.2006Endoscopy 2006; 38:867-72
Borovicka Jan, Binek Janek, Zuercher Ursula, Dorta G, Bauerfeind P, Ehmann T, Gschossmann J, Netzer P, Neuweiler Jörg, Fischer J, Meyenberger Christa
Serum immunoglobin G4 (IgG4): an important marker in autoimmune pancreatitis?
Sulz M, Geyer M, Peter S, Degen L. Serum immunoglobin G4 (IgG4): an important marker in autoimmune pancreatitis?. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2006; 136:544-7.
19.08.2006Serum immunoglobin G4 (IgG4): an important marker in autoimmune pancreatitis?
19.08.2006Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2006; 136:544-7
Sulz Michael, Geyer Martin, Peter Shajan, Degen Lukas
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
Meyer-Wyss B, Renner E, Arn M, Meyenberger C, Borovicka J, Rossi L, Criblez D, Oneta C, Gonvers J, Rammert C, Mullhaupt B, Helbling B, Egger H, Rich P, Swiss Association for the Study of the Liver (SASL). Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis. Journal of viral hepatitis 2006; 13:457-65.
01.07.2006Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
01.07.2006Journal of viral hepatitis 2006; 13:457-65
Meyer-Wyss B, Renner E L, Arn M, Meyenberger Christa, Borovicka Jan, Rossi L, Criblez D, Oneta C, Gonvers J-J, Rammert C, Mullhaupt B, Helbling B, Egger Hp, Rich P, Swiss Association for the Study of the Liver (SASL)
[Does the ultrasound make the clinical examination of the abdomen unnecessary?]
Meyenberger C. [Does the ultrasound make the clinical examination of the abdomen unnecessary?]. Therapeutische Umschau. Revue thérapeutique 2006; 63:475-8.
01.07.2006[Does the ultrasound make the clinical examination of the abdomen unnecessary?]
01.07.2006Therapeutische Umschau. Revue thérapeutique 2006; 63:475-8
Meyenberger Christa
Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes
Glas J, Folwaczny M, Ochsenkühn T, Brand S, Schnitzler F, Seiderer J, Lohse P, Schiemann U, Griga T, Epplen J, Klein W, Wetzke M, Mussack T, Müller-Myhsok B, Tonenchi L, Török H, Folwaczny C. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm Bowel Dis 2006; 12:606-11.
01.07.2006Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes
01.07.2006Inflamm Bowel Dis 2006; 12:606-11
Glas Jürgen, Folwaczny Matthias, Ochsenkühn Thomas, Brand Stephan, Schnitzler Fabian, Seiderer Julia, Lohse Peter, Schiemann Uwe, Griga Thomas, Epplen Joerg T, Klein Wolfram, Wetzke Martin, Mussack Thomas, Müller-Myhsok Bertram, Tonenchi Laurian, Török Helga-Paula, Folwaczny Christian
helicobacter pylori: Wann testen, wie testen?
van der Weg B, Meyenberger C, Borovicka J. helicobacter pylori: Wann testen, wie testen?. Hausarztpraxis 2006
01.06.2006helicobacter pylori: Wann testen, wie testen?
01.06.2006Hausarztpraxis 2006
van der Weg B, Meyenberger Christa, Borovicka Jan
Endoscopic transgastric debridement and drainage for splenic necrosis following an acute episode in chronic alcoholic pancreatitis
Binek J, Fretz C, Meyenberger C. Endoscopic transgastric debridement and drainage for splenic necrosis following an acute episode in chronic alcoholic pancreatitis. Endoscopy 2006; 38:639-40.
01.06.2006Endoscopic transgastric debridement and drainage for splenic necrosis following an acute episode in chronic alcoholic pancreatitis
01.06.2006Endoscopy 2006; 38:639-40
Binek Janek, Fretz C, Meyenberger Christa
Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma
Martin J, Thorgeirsson S, Brenner C, Cassio D, Ziemiecki A, St-Pierre M, Semela D, Lee J, Piguet A, Schmidt K, Magnino F, Dufour J. Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology 2006; 130:2179-88.
01.06.2006Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma
01.06.2006Gastroenterology 2006; 130:2179-88
Martin Juliette, Thorgeirsson Snorri S, Brenner Charles, Cassio Doris, Ziemiecki Andrew, St-Pierre Marie V, Semela David, Lee Ju-Seog, Piguet Anne-Christine, Schmidt Karin, Magnino Fabrice, Dufour Jean-François